|
1
|
Ranpise N, Jamkar P and Langote H: Do
fixed dose combinations play an important role in the management of
coexistent type two diabetes mellitus and hypertension? Ind J Pharm
Edu Res. 49:190–199. 2015.https://pdfs.semanticscholar.org/bb29/cc69f43e2026d0e6b8e1b107782de8c0b51b.pdf
View Article : Google Scholar
|
|
2
|
Hill MD: Stroke and diabetes mellitus.
Handb Clin Neurol. 126:167–174. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Janghorbani M and Amini M: Progression
from optimal blood glucose and pre-diabetes to type 2 diabetes in a
high risk population with or without hypertension in Isfahan, Iran.
Diabetes Res Clin Pract. 108:414–422. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guo K, Zhou Z, Jiang Y, Li W and Li Y:
Meta-analysis of prospective studies on the effects of nut
consumption on hypertension and type 2 diabetes mellitus. J
Diabetes. 7:202–212. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lan J, Zhao Y, Dong F, Yan Z, Zheng W, Fan
J and Sun G: Meta-analysis of the effect and safety of berberine in
the treatment of type 2 diabetes mellitus, hyperlipemia and
hypertension. J Ethnopharmacol. 161:69–81. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Danquah I, Dobrucky CL, Frank LK, Henze A,
Amoako YA, Bedu-Addo G, Raila J, Schulze MB, Mockenhaupt FP and
Schweigert FJ: Vitamin A: Potential misclassification of vitamin A
status among patients with type 2 diabetes and hypertension in
urban Ghana. Am J Clin Nutr. 102:207–214. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chung JO, Cho DH, Chung DJ and Chung MY:
Serum cystatin C levels are positively associated with
cardiovascular autonomic neuropathy in patients with type 2
diabetes. Exp Clin Endocrinol Diabetes. 123:627–631. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kjeldsen SE, Farsang C, Sleigh P and
Mancia G: World Health Organization; International Society of
Hypertension: 1999 WHO/ISH hypertension guidelines - highlights and
ESH update. J Hypertens. 19:2285–2288. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li N, Beck T, Chen J, Biermann C, Guo L,
Sun H, Gao F and Liu C: Assessment of thoracic aortic elasticity: A
preliminary study using electrocardiographically gated dual-source
CT. Eur Radiol. 21:1564–1572. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Edelman D, Dolor RJ, Coffman CJ, Pereira
KC, Granger BB, Lindquist JH, Neary AM, Harris AJ and Bosworth HB:
Nurse-led behavioral management of diabetes and hypertension in
community practices: A randomized trial. J Gen Intern Med.
30:626–633. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kamoi K: Usefulness of morning home blood
pressure measurements in patients with type 2 diabetes mellitus:
Results of a 10-year, prospective, longitudinal study. Clin Exp
Hypertens. 37:122–127. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hara Y, Kawagishi N, Nakanishi W, Tokodai
K, Nakanishi C, Miyagi S and Ohuchi N: Prevalence and risk factors
of obesity, hypertension, dyslipidemia and diabetes mellitus before
and after adult living donor liver transplantation. Hepatol Res.
45:764–770. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liang S, Cai GY and Chen XM: Clinical and
pathological factors associated with progression of diabetic
nephropathy. Nephrology (Carlton). 22 Suppl 4:14–19. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mozafari M, Nekooeian AA, Mashghoolozekr E
and Panjeshahin MR: The cardioprotective effects of resveratrol in
rats with simultaneous type 2 diabetes and renal hypertension. Nat
Prod Commun. 10:335–338. 2015.PubMed/NCBI
|
|
15
|
Zhou J, Liu C, Shan P, Zhou Y, Xu E and Ji
Y: Prevalence and distinguishing features of masked hypertension in
type 2 diabetic patients. J Diabetes Complications. 27:82–86. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ito WD, Lund N, Sager H, Becker W and
Wenzel U: Differential impact of diabetes mellitus type II and
arterial hypertension on collateral artery growth and concomitant
macrophage accumulation. Vasa. 44:31–41. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rodrigues KF, Pietrani NT, Bosco AA,
Campos FMF, Sandrim VC and Gomes KB: IL-6, TNF-α, and IL-10
levels/polymorphisms and their association with type 2 diabetes
mellitus and obesity in Brazilian individuals. Arch Endocrinol
Metab. 61:438–446. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Matsushita K, Sang Y, Ballew SH, Astor BC,
Hoogeveen RC, Solomon SD, Ballantyne CM, Woodward M and Coresh J:
Cardiac and kidney markers for cardiovascular prediction in
individuals with chronic kidney disease: The Atherosclerosis Risk
in Communities study. Arterioscler Thromb Vasc Biol. 34:1770–1777.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yan PJ, Xu Y, Wan Q, Feng J, Li H, Gao CL,
Yang J, Zhong HH and Zhang ZH: Decreased plasma neuregulin 4
concentration is associated with increased high-sensitivity
C-reactive protein in newly diagnosed type 2 diabetes mellitus
patients: A cross-sectional study. Acta Diabetol. 54:1091–1099.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chuengsamarn S, Rattanamongkolgul S,
Sittithumcharee G and Jirawatnotai S: Association of serum
high-sensitivity C-reactive protein with metabolic control and
diabetic chronic vascular complications in patients with type 2
diabetes. Diabetes Metab Syndr. 11:103–108. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li X, Wu TT, Chen J and Qiu W: Elevated
expression levels of serum insulin-like growth factor-1, tumor
necrosis factor-α and vascular endothelial growth factor 165 might
exacerbate type 2 diabetic nephropathy. J Diabetes Investig.
8:108–114. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Murai T, Takebe N, Nagasawa K, Todate Y,
Nakagawa R, Nakano R, Hangai M, Hasegawa Y, Takahashi Y, Yoshioka
K, et al: Association of epicardial adipose tissue with serum level
of cystatin C in type 2 diabetes. PLoS One. 12:e01847232017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Silva-E-Oliveira J, Amélio PM, Abranches
ILL, Damasceno DD and Furtado F: Heart rate variability based on
risk stratification for type 2 diabetes mellitus. Einstein (Sao
Paulo). 15:141–147. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bhavsar NA, Appel LJ, Kusek JW, Contreras
G, Bakris G, Coresh J and Astor BC: AASK Study Group: Comparison of
measured GFR, serum creatinine, cystatin C, and beta-trace protein
to predict ESRD in African Americans with hypertensive CKD. Am J
Kidney Dis. 58:886–893. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun W, Tadmori I, Yang L, Delgado M and
Ganea D: Vasoactive intestinal peptide (VIP) inhibits TGF-beta1
production in murine macrophages. J Neuroimmunol. 107:88–99. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Menzies JR, McKee R and Corbett AD:
Differential alterations in tachykinin NK2 receptors in isolated
colonic circular smooth muscle in inflammatory bowel disease and
idiopathic chronic constipation. Regul Pept. 99:151–156. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Grover M, Farrugia G, Lurken MS, Bernard
CE, Faussone-Pellegrini MS, Smyrk TC, Parkman HP, Abell TL, Snape
WJ, Hasler WL, et al: NIDDK Gastroparesis Clinical Research
Consortium: Cellular changes in diabetic and idiopathic
gastroparesis. Gastroenterology. 140(1575–85): e82011.
|
|
28
|
Iwasaki H, Kajimura M, Osawa S, Kanaoka S,
Furuta T, Ikuma M and Hishida A: A deficiency of gastric
interstitial cells of Cajal accompanied by decreased expression of
neuronal nitric oxide synthase and substance P in patients with
type 2 diabetes mellitus. J Gastroenterol. 41:1076–1087. 2006.
View Article : Google Scholar : PubMed/NCBI
|
